Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aleksander Chudnovsky

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Andrology|January 26, 2007
Copious pre-ejaculation: small glands--major headachesAleksander Chudnovsky, Craig S Niederberger
Journal of Andrology|May 25, 2007
Gonadotropin therapy for infertile men with hypogonadotropic hypogonadismAleksander Chudnovsky, Craig S Niederberger
Journal of Andrology|October 20, 2006
The foreskin dilemma: to cut or not to cutAleksander Chudnovsky, Craig S Niederberger
The Urologic Clinics of North America|April 22, 2008
Hormonal evaluation of the infertile male: has it evolved?Ernest M Sussman, Aleksander Chudnovsky, Craig S Niederberger
Journal of Sex & Marital Therapy|March 20, 2002
Characteristics of female patients with sexual dysfunction who also had a history of blunt perineal traumaRicardo Munarriz, Lily Talakoub, Nir N Somekh, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 4, 2025
Phase I/II Study of Subasumstat (TAK-981) in Combination With Rituximab in Relapsed/Refractory Non-Hodgkin LymphomaSarit E Assouline, Amitkumar Mehta, Walter Hanel, et al.
Lancet (London, England)|February 12, 2023
Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trialRobert J Motzer, Paul Russo, Viktor Grünwald, et al.
Targeted Oncology|September 2, 2023
Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 TrialRobert J Motzer, Paul Russo, Viktor Grünwald, et al.
Nature Medicine|September 8, 2020
Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trialRobert J Motzer, Paul B Robbins, Thomas Powles, et al.
Cancer Research Communications|October 24, 2025
A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic MalignanciesDejan Juric, Daniel Anderson, Afshin Dowlati, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Andrology|January 26, 2007
Copious pre-ejaculation: small glands--major headachesAleksander Chudnovsky, Craig S Niederberger
Journal of Andrology|May 25, 2007
Gonadotropin therapy for infertile men with hypogonadotropic hypogonadismAleksander Chudnovsky, Craig S Niederberger
Journal of Andrology|October 20, 2006
The foreskin dilemma: to cut or not to cutAleksander Chudnovsky, Craig S Niederberger
The Urologic Clinics of North America|April 22, 2008
Hormonal evaluation of the infertile male: has it evolved?Ernest M Sussman, Aleksander Chudnovsky, Craig S Niederberger
Journal of Sex & Marital Therapy|March 20, 2002
Characteristics of female patients with sexual dysfunction who also had a history of blunt perineal traumaRicardo Munarriz, Lily Talakoub, Nir N Somekh, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 4, 2025
Phase I/II Study of Subasumstat (TAK-981) in Combination With Rituximab in Relapsed/Refractory Non-Hodgkin LymphomaSarit E Assouline, Amitkumar Mehta, Walter Hanel, et al.
Lancet (London, England)|February 12, 2023
Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trialRobert J Motzer, Paul Russo, Viktor Grünwald, et al.
Targeted Oncology|September 2, 2023
Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 TrialRobert J Motzer, Paul Russo, Viktor Grünwald, et al.
Nature Medicine|September 8, 2020
Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trialRobert J Motzer, Paul B Robbins, Thomas Powles, et al.
Cancer Research Communications|October 24, 2025
A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic MalignanciesDejan Juric, Daniel Anderson, Afshin Dowlati, et al.
Pageof 2